ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

J&J start-up incubator slated for Washington, D.C.

by Marc S. Reisch
April 20, 2019 | APPEARED IN VOLUME 97, ISSUE 16

 

Johnson & Johnson plans to launch a 3,000 m2 JLabs start-up incubator at the Children’s National Research and Innovation Campus in Washington, DC. The facility will be open to drug, diagnostic, medical device, and other health technology start-ups. Included is a specialized zone managed with the US Biomedical Advanced Research and Development Authority and focused on countermeasures to chemical, biological, radiological, and nuclear threats. J&J is also launching a competition that will award up to $150,000 and residency at the new JLabs when it opens in 2020. Eligible are start-ups working on pediatric oncology, surgical care, and influenza treatment advances.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment